US Bancorp’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.6K Sell
2,459
-39
-2% -$1.19K ﹤0.01% 2505
2026
Q1
$83.2K Buy
2,498
+55
+2% +$1.84K ﹤0.01% 2485
2025
Q4
$84.5K Hold
2,443
﹤0.01% 2461
2025
Q3
$66.5K Buy
2,443
+97
+4% +$2.35K ﹤0.01% 2536
2025
Q2
$49.3K Buy
2,346
+520
+28% +$9.98K ﹤0.01% 2795
2025
Q1
$29.9K Buy
1,826
+2
+0.1% +$43 ﹤0.01% 2991
2024
Q4
$46.9K Buy
1,824
+110
+6% +$3.11K ﹤0.01% 2768
2024
Q3
$54.3K Buy
1,714
+689
+67% +$26.1K ﹤0.01% 2687
2024
Q2
$36K Buy
1,025
+79
+8% +$3.13K ﹤0.01% 2824
2024
Q1
$41.5K Buy
946
+578
+157% +$24.9K ﹤0.01% 2790
2023
Q4
$13.1K Buy
368
+114
+45% +$3.4K ﹤0.01% 3222
2023
Q3
$6.85K Hold
254
﹤0.01% 3316
2023
Q2
$5.97K Buy
254
+13
+5% +$267 ﹤0.01% 3431
2023
Q1
$3.31K Sell
241
-34
-12% -$566 ﹤0.01% 3645
2022
Q4
$5K Sell
275
-1,532
-85% -$25.8K ﹤0.01% 3510
2022
Q3
$27K Buy
1,807
+325
+22% +$4.22K ﹤0.01% 2875
2022
Q2
$21K Buy
1,482
+1,367
+1,189% +$15.2K ﹤0.01% 3022
2022
Q1
$1K Hold
115
﹤0.01% 3951
2021
Q4
$3K Buy
+115
New +$2.67K ﹤0.01% 3803
2019
Q4
Sell
-500
Closed -$5K 3685
2019
Q3
$5K Hold
500
﹤0.01% 3241
2019
Q2
$5K Buy
+500
New +$5.44K ﹤0.01% 3277

Other funds holding IDYA

US Bancorp's IDYA Position: Q2 2026 in Review

US Bancorp reduced its IDEAYA Biosciences (IDYA) stake by 1.6% in Q2 2026, selling an estimated $1.19K and leaving 2,459 shares worth $91.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

US Bancorp first reported a position in IDYA in Q2 2019 and has held it in 21 quarters since. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • US Bancorp held 2,459 shares of IDEAYA Biosciences worth $91.6K as of Q2 2026.
  • US Bancorp sold 39 IDEAYA Biosciences shares in Q2 2026, an estimated $1.19K.
  • IDEAYA Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2505 holding.
  • US Bancorp first reported a position in IDEAYA Biosciences in Q2 2019 and has held it in 21 quarters since.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.